Table 1

Patient characteristics

Patient number Sex Age Site* Duration of RA Treatment*
A Patients with RA providing synovial biopsy specimens at arthroscopy
RA-1F55Elbow8 moNSAID
RA-2M30Knee9 moNSAID
RA-3M25Knee4 moNSAID
RA-4F76Knee8 moNSAID, AUR
RA-5F56Knee9 moNSAID
RA-6F44Knee5 moNSAID
RA-7F46Knee8 moNSAID
RA-8M22Knee1 moNSAID
RA-9M55Knee4 moNSAID
RA-10M80Knee1 moNSAID, SSA
RA-11F54Knee2 moNSAID
RA-12F42Knee1 yAUR
RA-13F47Knee5 moNSAID
RA-14F47Knee1.5 yNSAID, SSA
RA-15F52Knee1.5 yPred
RA-16F48Knee27 yNSAID, Pred
RA-17F34Knee8 yMTX
RA-18F45Knee6 yMTX
RA-19F27Knee6 yMTX
RA-20M48Knee29 ySSA
B Patients with RA providing synovial specimens at surgery
RA-21M66MTP146 yNSAID, CsA
RA-22F69MTP110 yMTX
RA-23F43MTP18 yNone
RA-24F71MTP128 yNSAID, Pred, MTX
RA-25F58MTP137 yNSAID
RA-26F51MTP113 yNSAID, Pred, MTX
RA-27F62MTP112 yNSAID, AMA
RA-28F79MTP117 yNSAID, Pred
RA-29F69MTP137 yNSAID,
RA-30F42MTP112 yCsA, Pred
RA-31F72Knee32 yNSAID, Pred
RA-32F37MTP115 yNSAID
RA-33F45Hip11 yNSAID
RA-34F84Hip22 yNSAID, Pred
RA-35F54Hip26 yNSAID
RA-36F66Hip17 yNone
RA-37F86Knee30 yNone
RA-38F57Knee23 yNSAID
RA-39F57Knee23 yNSAID
RA-40F49Hip23 yNSAID
C Controls with hallux valgus
HV-41M77MTP1None
HV-42F55MTP1None
HV-43M82MTP1None
HV-44F54MTP1None
HV-45F49MTP1None
HV-46F22MTP1None
HV-47F76MTP1None
HV-48F53MTP1None
  • NSAID = non-steroidal anti-inflammatory drug; AUR = auranofin; SSA = sulfasalazine; Pred = prednisone 5 mg; MTX = methotrexate; CsA = cyclosporin A; AMA = antimalarial drug; MTP1 - first metatarsophalangeal joint.